Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Celebrity Endorsers “Shine A Spotlight” But Bring Costs, Risks

This article was originally published in The Tan Sheet

Executive Summary

Celebrity endorsers can "create an emotional bridge" between consumers and brands, among other benefits, but they also pose risks and may not be cost-effective or appropriate for OTC and supplement products.

You may also be interested in...



Pricing Analytics Guide OTC Brands Out Of Private Label Trap

Brands should focus on building their equity and innovating to differentiate from private label, Marketing Management Analytics says in an interview. MMA works with clients such as GlaxoSmithKline to optimize retail pricing for OTC drugs and supplements based on pricing analytics and predictive modeling.

Pricing Analytics Guide OTC Brands Out Of Private Label Trap

Brands should focus on building their equity and innovating to differentiate from private label, Marketing Management Analytics says in an interview. MMA works with clients such as GlaxoSmithKline to optimize retail pricing for OTC drugs and supplements based on pricing analytics and predictive modeling.

Activist Investor May Push P&G To Sell Non-Core Brands, Oust CEO McDonald

Changes may be ahead for Procter & Gamble following William Ackman and Pershing Square Capital Management’s investment in the consumer products giant. Analysts suggest the activist investor may push to replace CEO Bob McDonald and divest non-core brands.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104698

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel